Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.
暂无分享,去创建一个
T. Shim | Ji‐Hyun Lee | Sang-Do Lee | Eun-Kyung Kim | Yun-Song Lee | K. Choe | Sang-Eun Kim | Dong-Soon Lee | Y. Oh | J. Lee | Dongsoon Lee
[1] N. Voelkel,et al. An animal model of autoimmune emphysema. , 2005, American journal of respiratory and critical care medicine.
[2] J. Tichelaar,et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. , 2005, American journal of respiratory cell and molecular biology.
[3] Irina Petrache,et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.
[4] A. Churg,et al. Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse , 2004 .
[5] J. Hogg,et al. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.
[6] A. Churg,et al. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. , 2004, American journal of respiratory cell and molecular biology.
[7] J. D’Armiento,et al. Extracellular Regulated Kinase/Mitogen Activated Protein Kinase Is Up-regulated in Pulmonary Emphysema and Mediates Matrix Metalloproteinase-1 Induction by Cigarette Smoke* , 2004, Journal of Biological Chemistry.
[8] N. Thomson,et al. A Novel Anti-Inflammatory Role of Simvastatin in a Murine Model of Allergic Asthma1 , 2004, The Journal of Immunology.
[9] D. Gardner,et al. Tumor Necrosis Factor-α Inhibits Endothelial Nitric-oxide Synthase Gene Promoter Activity in Bovine Aortic Endothelial Cells* , 2004, Journal of Biological Chemistry.
[10] A. M. Houghton,et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. , 2003, The American journal of pathology.
[11] G. Berry,et al. Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells , 2003, Circulation.
[12] R. Johns,et al. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. , 2003, American journal of physiology. Heart and circulatory physiology.
[13] S. Hazen,et al. Oxidative and nitrosative events in asthma. , 2003, Free radical biology & medicine.
[14] M. d’Ortho,et al. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats. , 2003, Human gene therapy.
[15] B. Longoni,et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[16] N. Voelkel,et al. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. , 2003, American journal of respiratory and critical care medicine.
[17] J. Ambrose,et al. Reactive Oxygen Species Are Involved in Smoking-Induced Dysfunction of Nitric Oxide Biosynthesis and Upregulation of Endothelial Nitric Oxide Synthase: An In Vitro Demonstration in Human Coronary Artery Endothelial Cells , 2003, Circulation.
[18] Josep Roca,et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[19] V. Peinado,et al. Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[20] M. Gaxiola,et al. Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in Guinea pigs. , 2003, Chest.
[21] A. Churg,et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. , 2003, American journal of respiratory and critical care medicine.
[22] C. Napoli,et al. Statin effects beyond lipid lowering--are they clinically relevant? , 2003, European heart journal.
[23] R. Madhok,et al. A Novel Anti-Inflammatory Role for Simvastatin in Inflammatory Arthritis 1 , 2003, The Journal of Immunology.
[24] K. Kaibuchi,et al. Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells , 2002, Molecular and Cellular Biology.
[25] G. Berry,et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. , 2002, American journal of respiratory and critical care medicine.
[26] P. Barnes,et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[27] N. Turner,et al. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. , 2002, Journal of vascular surgery.
[28] P. Barnes,et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.
[29] Sakae Tanaka,et al. Macrophage Migration Inhibitory Factor Up-regulates Matrix Metalloproteinase-9 and -13 in Rat Osteoblasts , 2002, The Journal of Biological Chemistry.
[30] Á. Pascual,et al. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. , 2002, Atherosclerosis.
[31] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[32] P. Hansen,et al. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. , 2001, The Biochemical journal.
[33] K. Node,et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.
[34] A. Harf,et al. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. , 2001, European Respiratory Journal.
[35] V. Peinado,et al. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. , 2001, American journal of respiratory and critical care medicine.
[36] Joerg Kallen,et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site , 2001, Nature Medicine.
[37] S. Wright,et al. Statins suppress THP‐1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation , 2001, Journal of leukocyte biology.
[38] R. Homer,et al. Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.
[39] B. Ma,et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.
[40] F. Yamasawa,et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[41] U. Laufs,et al. 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * , 1999, The Journal of Biological Chemistry.
[42] V. Peinado,et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[43] Yunchao Su,et al. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. , 1998, American journal of respiratory cell and molecular biology.
[44] B. Baxter,et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[45] U. Laufs,et al. Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase* , 1998, The Journal of Biological Chemistry.
[46] A. Namboodiri,et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. , 1997, The Journal of clinical investigation.
[47] A. López-Farré,et al. Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha , 1997, Molecular and cellular biology.
[48] A. Carayon,et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. , 1997, Cardiovascular research.
[49] S. Basili,et al. Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease , 1994, Thrombosis and Haemostasis.
[50] C. M. Blow,et al. Nicotine and cigarette smoking: effects on the ultrastructure of aortic endothelium. , 1990, International journal of experimental pathology.
[51] J. Hogg,et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. , 1988, Thorax.
[52] Thurlbeck Wm. Measurement of pulmonary emphysema. , 1967 .
[53] H. W. Chalkley,et al. A Method for Estimating Volume-Surface Ratios. , 1949, Science.